Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2009/005092, filed Sep 11, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,492,503 | Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method In force · High confidence | Nektar Therapeutics | In force | High confidence | ||
| US 9,579,392 | Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method In force · High confidence | Nektar Therapeutics | In force | High confidence | ||
| US 10,759,906 | Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method In force · High confidence | Nektar Therapeutics | In force | High confidence | ||
| US 11,634,540 | Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method In force · High confidence | Nektar Therapeutics | In force | High confidence | ||
| US 9,228,053 | Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method In force · High confidence | Nektar Therapeutics | In force | High confidence | ||
| US 11,220,575 | Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method Lapsed Jan 11, 2026 on the fee record High confidence | Nektar Therapeutics | Lapsed Jan 11, 2026 on the fee record | High confidence | ||
| US 9,908,970 | Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method Lapsed Mar 6, 2026 on the fee record High confidence | Nektar Therapeutics | Lapsed Mar 6, 2026 on the fee record | High confidence |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Nektar Therapeutics.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.